Is Kingstone Cos., Inc. overvalued or undervalued?

As of 7 November 2025, the valuation grade for Kingstone Cos., Inc. moved from fair to attractive, indicating a more favorable assessment of its value. The company appears to be undervalued, particularly when considering its P/E ratio of 11, which is significantly lower than its peer Crawford & Co. at 17.88, and its EV to EBITDA ratio of 76.30, which is higher than the industry average. Additionally, the price to book value stands at 2.87, suggesting potential for growth relative to its book value.
In comparison to its peers, Kingstone Cos., Inc. shows a more attractive valuation with a P/E of 7.47 for its closest competitor, GoHealth, Inc., which has a P/E of 2.12, indicating that Kingstone is positioned better in terms of earnings potential. While the stock's return data is not available for a direct comparison with the S&P 500, the overall valuation metrics suggest that Kingstone Cos., Inc. is well-positioned for potential appreciation in value.